urapidil has been researched along with Blood Pressure, High in 182 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nitroglycerin (n=91) for 7 days." | 9.24 | Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. ( Chen, XM; Fu, Y; Guo, JC; He, JY; Hua, Q; Li, J; Qin, J; Qin, S; Wang, Z; Yang, W; Zhan, H; Zhou, YJ, 2017) |
| "To study the effect of urapidil combined with phentolamine in the management of hypertension during extracorporeal circulation." | 9.19 | [Effect of urapidil combined with phentolamine on hypertension during extracorporeal circulation]. ( Chen, B; Liu, Y; Tu, F; Wang, F, 2014) |
| "Urapidil proved to be equally effective as dihydralazine in lowering BP in patients with pre-eclampsia, but showed a better controllability and tolerability." | 9.12 | Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. ( Bartz, C; Briese, V; Heilmann, L; Hopp, H; Schauf, B; Wacker, JR; Wagner, BK, 2006) |
| "Since renal sympathetic nerves are involved in the regulation of sodium excretion, we investigated whether treatment with urapidil, an alpha1-adrenoceptor blocking agent which also lowers sympathetic activity, alters sodium excretory capacity in patients with essential hypertension." | 9.09 | Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension. ( de Leeuw, PW; Fuss-Lejeune, M; Kroon, AA; Lavrijssen, AT; Schiffers, PM, 2000) |
| "To assess the effect of a single prophylactic dose of urapidil for arterial hypertension during the period before start of extracorporeal circulation." | 9.09 | [Efficacy of a single dose of urapidil for preventing arterial hypertension during the pre-bypass period in coronary surgery]. ( Ballester, JA; Escobar, A; Lasuen, J; Olmos, M; Vidarte, MA, 2000) |
| "To assess the safety and efficacy of urapidil compared to sodium nitroprusside in the treatment of hypertensive emergencies." | 9.08 | Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. ( Binder, M; Bur, A; Herkner, H; Hirschl, MM; Laggner, AN; Müllner, M; Woisetschläger, C, 1997) |
| "Since urapidil decreased the high blood pressure in patients with pre-eclampsia without serious side-effects urapidil appears preferable superior to dihydralazine." | 9.08 | Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. ( Bastert, G; Wacker, J; Walter-Sack, I; Werner, P, 1998) |
| " Therefore, urapidil is a valuable alternative to nitroglycerin in patients with pulmonary edema and systemic hypertension." | 9.08 | The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. ( Binder, M; Hirschl, MM; Kaff, A; Raab, H; Schreiber, W; Woisetschläger, C, 1998) |
| "To evaluate the efficacy and tolerability of urapidil (a new central and peripheral antihypertensive agent) in patients with mild to moderate essential hypertension." | 9.07 | [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study]. ( Amodeo, C; Barros, LM; Batlouni, M; Sousa, JE, 1993) |
| "20 patients who developed arterial hypertension following coronary artery bypass grafting were randomly treated with either sodium nitroprusside (SNP) or urapidil." | 9.06 | [The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery]. ( Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; van Aken, H, 1989) |
| "In order to evaluate the usefulness of urapidil in the treatment of severe hypertension and in the long-term treatment of essential hypertension, two open multicentre studies were performed." | 9.06 | Urapidil in patients with severe hypertension and in long-term treatment. ( Iimura, O; Inagaki, Y; Ishii, M; Kaneko, Y; Mizuno, Y; Shionoiri, H; Takeda, T; Taniguchi, K; Yasuda, H; Yoshinaga, K, 1988) |
| "A multicentre double-blind comparative study of urapidil and prazosin was performed in 412 outpatients with mild to moderate essential hypertension." | 9.06 | Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension. ( Kaneko, Y, 1988) |
| "The blood pressure-lowering effect and tolerability of urapidil 120 mg once daily versus urapidil 60 mg twice daily was compared in 36 outpatients with newly diagnosed mild to moderate essential hypertension." | 9.06 | Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring. ( Cuocolo, A; Feldhaus, P; Lembo, G; Rosiello, G; Steinijans, VW; Trimarco, B; Vecchione, F; Volpe, M, 1988) |
| "5, 15, 30, 45, 60, 90, and 120 mg single daily doses of urapidil were compared with those of placebo in 10 patients with essential hypertension." | 9.06 | Acute effects of increasing doses of urapidil in patients with hypertension. ( Bryant, PJ; Byyny, RL; Cady, WJ; Culbertson, VL; Nies, AS; Piepho, RW; Rubison, RM, 1986) |
| "The hypertensive effect of urapidil, a new antihypertensive agent that acts via central and peripheral alpha-adrenoceptors, has been compared with that of metoprolol in 40 patients with mild essential hypertension." | 9.06 | Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension. ( Boni, S; Guffanti, E; Leonetti, G; Mazzola, C; Meani, A; Zanchetti, A, 1986) |
| " The haemodynamic effects of the alpha-adrenergic blocking drugs phentolamine and urapidil, two alpha-adrenergic blocking drugs with a different alpha-receptor subtype specificity, when used to control intra-operative hypertension were evaluated." | 9.05 | Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery. ( Hess, W; Schulte-Sasse, U; Tarnow, J; Veit, S, 1985) |
| "PubMed, EMBASE, the Cochrane Library and China National Knowledge Infrastructure were searched for randomized studies that compared urapidil treatment with nitroglycerin treatment for hypertensive patients with acute heart failure." | 9.01 | Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis. ( Ding, H; Feng, S; Li, Y; Ning, G; Peng, P; Shi, H; Shi, J; Xing, C; Zheng, P, 2019) |
| "The review considers the possibility of using capsule form urapidila for combination therapy for treatment-resistant hypertension." | 8.88 | [Features of urapidil in treatment of resistant hypertension]. ( Minushkina, LO, 2012) |
| "Previous clinical studies have reported that urapidil can effectively treat patients with senile hypertension (SH) and acute heart failure (AHF)." | 7.91 | Efficacy of urapidil for the treatment of patients with senile hypertension and acute heart failure. ( Ding, GR; Feng, JF; Ni, JM; Xie, YZ; Zhang, SJ, 2019) |
| "Perioperative treatment with the selective α1 blocker urapidil remains a simple and cost effective method in the treatment regime of patients with pheochromocytoma." | 7.79 | Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method. ( Bechstein, WO; Bojunga, J; Habbe, N; Holzer, K; Ruger, F, 2013) |
| "To compare the clinical efficacy and safety of sublingual nifedipine and intravenous urapidil in the treatment of acute postoperative hypertension." | 7.77 | [Efficacy of sublingual nifedipine and intravenous urapidil for treatment of acute postoperative hypertension]. ( Lou, N; Wang, DF; Wang, Z, 2011) |
| "To study the efficacy and tolerability of urapidil in patients with mild and moderate arterial hypertension, including ambulatory blood pressure monitoring (ABPM)." | 7.68 | [Treatment of systemic arterial hypertension with urapidil. Study in mild and moderate hypertension with ambulatory monitoring of arterial pressure]. ( Nobre, F; Nogueira, JL, 1993) |
| "The clinical response and pharmacokinetics of intravenous urapidil were studied in patients with uncontrolled severe hypertension." | 7.67 | Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension. ( Bottorff, MB; Gerlach, PA; Hoon, TJ; Ramanathan, KB; Rodman, JH, 1988) |
| "Systemic, renal and splanchnic hemodynamics and certain reflex and endocrine responses were determined in 10 patients with essential hypertension before and after intravenous administration of urapidil, a new antihypertensive agent that acts through both central and peripheral alpha-adrenergic inhibitory mechanisms." | 7.67 | Immediate hemodynamic effects of urapidil in patients with essential hypertension. ( Amodeo, C; Frohlich, ED; Kobrin, I; Messerli, FH; Ventura, HO, 1985) |
| "The influence of urapidil, an arylpiperazinederivate, on intracranial pressure (ICP), mean arterial pressure (MAP) and cerebral perfusion pressure (CPP) was investigated in dogs with (group II) and without (group I) intracranial hypertension." | 7.66 | The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension. ( Anger, C; Lawin, P; Puchstein, C; Van Aken, H, 1983) |
| "Atenolol treatment had neutral properties in some metabolic aspects, but deleterious effects on lipid status." | 6.68 | Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension. ( Haenni, A; Lithell, H, 1996) |
| "Urapidil (U) has both peripheral alpha-1-adrenoreceptor blocking activity and a central antihypertensive effect at the level of the 5HT-1A serotonergic receptor, resulting in enhanced peripheral sympathetic inhibition (3,4)." | 6.67 | Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery. ( Koolen, JJ; Van der Stroom, JG; Van Wezel, HB; Van Zwieten, PA; Visser, CA, 1994) |
| "Urapidil was found effective in the treatment of hypertension during extracorporeal circulation." | 6.65 | Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine. ( Barankay, A; Göb, E; Richter, JA, 1981) |
| "Urapidil is a peripheral postsynaptic alpha 1-adrenoceptor antagonist with central agonistic action at serotonin 5-HT1A receptors." | 6.40 | Urapidil. A reappraisal of its use in the management of hypertension. ( Dooley, M; Goa, KL, 1998) |
| "A clear trend towards a reduction of cardiac hypertrophy during the treatment is suggested by the significant decrements of the indices measured." | 6.39 | Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil. ( Genovesi-Ebert, A; Ghione, S; Marabotti, C; Noseda, A; Spinazzi, A, 1994) |
| "Urapidil is a postsynaptic alpha 1-adrenoceptor antagonist with a pharmacodynamic profile similar to prazosin." | 6.38 | Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. ( Langtry, HD; Mammen, GJ; Sorkin, EM, 1989) |
| "Urapidil is an alpha 1-adrenoceptor antagonist which also has a central antihypertensive effect, the mechanism of which has yet to be conclusively defined." | 6.37 | Urapidil in the treatment of hypertension. ( Rosendorff, C, 1988) |
| "Urapidil is a potent antihypertensive drug that has been in clinical use for more than 20 years." | 5.35 | Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. ( Allegaert, K; Hanssens, M; Vanhaesebrouck, S, 2009) |
| "Urapidil is a vasodilator acting on peripheral vessels by alpha-1 adrenoceptor blockade, and on central nervous system by alphaadrenoceptor blockade on the tractus solitarius nuclei and stimulation of serotoninergic receptors." | 5.29 | [Role of urapidil in the treatment of acute hypertension]. ( Bastien, O; Bonnefoy, E; Dalmas, JP; Filley, S; George, M; Lehot, JJ, 1995) |
| "treatment with urapidil at a diastolic blood pressure of more than 100 mm Hg." | 5.29 | [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. ( Bastert, G; Grischke, EM; Müller, J; Unkels, R; Wacker, J, 1994) |
| "Urapidil was given intravenously in the emergent treatment to the group of 23 pts in the mean dose of 50 mg." | 5.29 | [Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies]. ( Błaszyk, K; Cieśliński, A; Grajek, S; Mitkowski, P; Popiel, M; Skorupski, W; Wnuk, H, 1995) |
| "Patients (>60 y) with hypertension and heart failure were randomly assigned to receive intravenous urapidil (n=89) or nitroglycerin (n=91) for 7 days." | 5.24 | Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. ( Chen, XM; Fu, Y; Guo, JC; He, JY; Hua, Q; Li, J; Qin, J; Qin, S; Wang, Z; Yang, W; Zhan, H; Zhou, YJ, 2017) |
| "To study the effect of urapidil combined with phentolamine in the management of hypertension during extracorporeal circulation." | 5.19 | [Effect of urapidil combined with phentolamine on hypertension during extracorporeal circulation]. ( Chen, B; Liu, Y; Tu, F; Wang, F, 2014) |
| "Urapidil proved to be equally effective as dihydralazine in lowering BP in patients with pre-eclampsia, but showed a better controllability and tolerability." | 5.12 | Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. ( Bartz, C; Briese, V; Heilmann, L; Hopp, H; Schauf, B; Wacker, JR; Wagner, BK, 2006) |
| "Since renal sympathetic nerves are involved in the regulation of sodium excretion, we investigated whether treatment with urapidil, an alpha1-adrenoceptor blocking agent which also lowers sympathetic activity, alters sodium excretory capacity in patients with essential hypertension." | 5.09 | Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension. ( de Leeuw, PW; Fuss-Lejeune, M; Kroon, AA; Lavrijssen, AT; Schiffers, PM, 2000) |
| "To assess the effect of a single prophylactic dose of urapidil for arterial hypertension during the period before start of extracorporeal circulation." | 5.09 | [Efficacy of a single dose of urapidil for preventing arterial hypertension during the pre-bypass period in coronary surgery]. ( Ballester, JA; Escobar, A; Lasuen, J; Olmos, M; Vidarte, MA, 2000) |
| "To assess the safety and efficacy of urapidil compared to sodium nitroprusside in the treatment of hypertensive emergencies." | 5.08 | Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. ( Binder, M; Bur, A; Herkner, H; Hirschl, MM; Laggner, AN; Müllner, M; Woisetschläger, C, 1997) |
| "When hypertension (defined as mean arterial pressure > 85 mmHg) developed within the first 2 hours after arrival in the intensive care unit, patients received urapidil (n = 62) or ketanserin (n = 60) to reach a mean arterial pressure between 65 and 75 mmHg." | 5.08 | A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery. ( Kal, JE; Kooyman, J; Korsten, HH; Langemeijer, JJ; Porsius, M; van den Ende, R; van der Starre, PJ; van der Stroom, JG; van Wezel, HB; van Zwieten, PA, 1997) |
| "Since urapidil decreased the high blood pressure in patients with pre-eclampsia without serious side-effects urapidil appears preferable superior to dihydralazine." | 5.08 | Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. ( Bastert, G; Wacker, J; Walter-Sack, I; Werner, P, 1998) |
| " Therefore, urapidil is a valuable alternative to nitroglycerin in patients with pulmonary edema and systemic hypertension." | 5.08 | The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. ( Binder, M; Hirschl, MM; Kaff, A; Raab, H; Schreiber, W; Woisetschläger, C, 1998) |
| " In the light of recent evidence that some antihypertensive drugs with alpha-1 blocking properties reduce blood pressure (BP) and total cholesterol (chol), increasing chol content in the non-atherogenic high density lipoproteins (HDL-chol), the effects of urapidil, a peripheral alpha-1 adrenoceptor antagonist, with a central action component on BP and plasma lipids were evaluated in 49 mild, hypertensive patients with mild to moderately severe hypercholesterolemia (serum chol 220-320 mg/dl) for a 6 month period in a double-blind randomized study versus placebo." | 5.07 | Urapidil in hypercholesterolemic hypertensive patients. ( Ferrara, LA; Fogari, R; Leonetti, G; Mancini, M; Mazzola, C; Zanchetti, A, 1994) |
| "To evaluate the efficacy and tolerability of urapidil (a new central and peripheral antihypertensive agent) in patients with mild to moderate essential hypertension." | 5.07 | [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study]. ( Amodeo, C; Barros, LM; Batlouni, M; Sousa, JE, 1993) |
| "To define the efficacy and tolerability of urapidil as a monotherapy in ambulatory patients with hypertension, we compared urapidil with a standard first-line antihypertensive agent, hydrochlorothiazide (HCT), in a multicentre general practice trial." | 5.06 | Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide. ( Distler, A; Haerlin, R; Hilgenstock, G; Passfall, J, 1990) |
| "In a cross-over study, the effect of 25 mg urapidil infusion (U, Ebrantil 25, Byk-Gulden, FRG) on serotonin (5HT) metabolism and platelet aggregation (PA) was compared with the effect of placebo (P) in 7 patients with essential hypertension." | 5.06 | Acute effect of urapidil on peripheral serotonin metabolism. ( Blazícek, P; Dzúrik, R; Fedelesová, V; Sebeková, K, 1990) |
| "Thirty patients who developed arterial hypertension following coronary artery bypass grafting, despite sedation, were treated randomly with sodium nitroprusside (SNP), ketanserin or urapidil." | 5.06 | Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting. ( Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; Van Aken, H, 1990) |
| "In a multi-center, double-blind parallel-group study involving patients with essential hypertension (grade I/II), the antihypertensive effect and toleration of the postsynaptic alpha-1 receptor blocker, urapidil, was compared with that of the calcium antagonist, nifedipine." | 5.06 | [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study]. ( Feldhaus, P; Haerlin, R; Stumpe, KO, 1989) |
| "20 patients who developed arterial hypertension following coronary artery bypass grafting were randomly treated with either sodium nitroprusside (SNP) or urapidil." | 5.06 | [The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery]. ( Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; van Aken, H, 1989) |
| "In order to evaluate the acute effects of urapidil on renal vascular tone and on pressor systems we performed a randomised placebo-controlled crossover study in 8 patients with uncomplicated essential hypertension." | 5.06 | Renal haemodynamic and neurohumoral responses to urapidil in hypertensive man. ( Birkenhäger, WH; de Bruyn, HA; de Leeuw, PW; van Es, PN, 1988) |
| "In order to evaluate the usefulness of urapidil in the treatment of severe hypertension and in the long-term treatment of essential hypertension, two open multicentre studies were performed." | 5.06 | Urapidil in patients with severe hypertension and in long-term treatment. ( Iimura, O; Inagaki, Y; Ishii, M; Kaneko, Y; Mizuno, Y; Shionoiri, H; Takeda, T; Taniguchi, K; Yasuda, H; Yoshinaga, K, 1988) |
| "A multicentre double-blind comparative study of urapidil and prazosin was performed in 412 outpatients with mild to moderate essential hypertension." | 5.06 | Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension. ( Kaneko, Y, 1988) |
| "The blood pressure-lowering effect and tolerability of urapidil 120 mg once daily versus urapidil 60 mg twice daily was compared in 36 outpatients with newly diagnosed mild to moderate essential hypertension." | 5.06 | Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring. ( Cuocolo, A; Feldhaus, P; Lembo, G; Rosiello, G; Steinijans, VW; Trimarco, B; Vecchione, F; Volpe, M, 1988) |
| "5, 15, 30, 45, 60, 90, and 120 mg single daily doses of urapidil were compared with those of placebo in 10 patients with essential hypertension." | 5.06 | Acute effects of increasing doses of urapidil in patients with hypertension. ( Bryant, PJ; Byyny, RL; Cady, WJ; Culbertson, VL; Nies, AS; Piepho, RW; Rubison, RM, 1986) |
| "The hypertensive effect of urapidil, a new antihypertensive agent that acts via central and peripheral alpha-adrenoceptors, has been compared with that of metoprolol in 40 patients with mild essential hypertension." | 5.06 | Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension. ( Boni, S; Guffanti, E; Leonetti, G; Mazzola, C; Meani, A; Zanchetti, A, 1986) |
| " The haemodynamic effects of the alpha-adrenergic blocking drugs phentolamine and urapidil, two alpha-adrenergic blocking drugs with a different alpha-receptor subtype specificity, when used to control intra-operative hypertension were evaluated." | 5.05 | Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery. ( Hess, W; Schulte-Sasse, U; Tarnow, J; Veit, S, 1985) |
| "The antihypertensive effects of urapidil and clonidine have been studied in a double-blind cross-over trial in 11 hypertensive outpatients with mild to moderate hypertension, at rest and during isometric exercise." | 5.05 | Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study. ( Heikkilä, O; Jääskeläinen, T; Jounela, AJ; Kanniainen, E; Lilja, M, 1985) |
| "PubMed, EMBASE, the Cochrane Library and China National Knowledge Infrastructure were searched for randomized studies that compared urapidil treatment with nitroglycerin treatment for hypertensive patients with acute heart failure." | 5.01 | Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis. ( Ding, H; Feng, S; Li, Y; Ning, G; Peng, P; Shi, H; Shi, J; Xing, C; Zheng, P, 2019) |
| "The review considers the possibility of using capsule form urapidila for combination therapy for treatment-resistant hypertension." | 4.88 | [Features of urapidil in treatment of resistant hypertension]. ( Minushkina, LO, 2012) |
| "Urapidil, an antihypertensive agent with dual action (alpha 1-adrenergic antagonist and 5HT1A agonist) is well established in the treatment of arterial hypertension." | 4.79 | Review of studies with urapidil in elderly hypertensives. ( Hansson, L; Petitet, A, 1995) |
| "Urapidil is a selective alpha 1-adrenoceptor antagonist with central antihypertensive action which is increasingly used in the treatment of hypertension." | 4.77 | Clinical pharmacokinetics of urapidil. ( Haerlin, R; Kirsten, R; Nelson, K; Steinijans, VW; Zech, K, 1988) |
| "Previous clinical studies have reported that urapidil can effectively treat patients with senile hypertension (SH) and acute heart failure (AHF)." | 3.91 | Efficacy of urapidil for the treatment of patients with senile hypertension and acute heart failure. ( Ding, GR; Feng, JF; Ni, JM; Xie, YZ; Zhang, SJ, 2019) |
| "Perioperative treatment with the selective α1 blocker urapidil remains a simple and cost effective method in the treatment regime of patients with pheochromocytoma." | 3.79 | Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method. ( Bechstein, WO; Bojunga, J; Habbe, N; Holzer, K; Ruger, F, 2013) |
| "To compare the clinical efficacy and safety of sublingual nifedipine and intravenous urapidil in the treatment of acute postoperative hypertension." | 3.77 | [Efficacy of sublingual nifedipine and intravenous urapidil for treatment of acute postoperative hypertension]. ( Lou, N; Wang, DF; Wang, Z, 2011) |
| "Urapidil has been successfully administered also in patients with congestive heart failure and in hypertensive crises during or following surgical procedures; in all these conditions urapidil lowers total peripheral resistance, but blood pressure is lowered only in patients with hypertensive crises and no clinically relevant reduction in blood pressure is found in patients with congestive heart failure." | 3.76 | Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients. ( Leonetti, G; Terzoli, L; Zanchetti, A, 1988) |
| " Hypertension was treated in 12 patients (esmolol n = 6, urapidil n = 5, nicardipine)." | 3.73 | Improvement of donor myocardial function after treatment of autonomic storm during brain death. ( Audibert, G; Charpentier, C; Charretier, PA; Devaux, Y; Grégoire, H; Longrois, D; Mertes, PM; Perrier, JF; Seguin-Devaux, C, 2006) |
| "We review the use of urapidil to manage hypertension in two patients undergoing adrenalectomy for pheochromocytoma and aldosterone producing adenoma." | 3.70 | [Control of hypertensive crisis with urapidil in two cases of adrenalectomy]. ( Bovaira Forner, M; Cabezudo de la Muela, L; Domingo Triadó, V; Moro Blázquez, B; Negueroles Albuixech, D; Viñoles Pérez, JM, 1998) |
| " Nitroglycerin was named as first choice only for pulmonary oedema or myocardial infarction." | 3.70 | [Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis. An inquiry in 56 internal medicine clinics]. ( Grieshaber, M; Schwietzer, G; Stahl, RA; Wenzel, UO, 1998) |
| "Urapidil effects on oxidant stress were studied in 36 patients with hypertension stage I-III running with crises." | 3.70 | [Urapidil effects on oxidative stress in hypertensive crises]. ( Davydov, BV; Golikov, AP; Golikov, PP; Marchenko, VV; Nikolaeva, NIu; Polumiskov, VIu; Riabinin, VA; Semenova, EV, 2000) |
| "To study the efficacy and tolerability of urapidil in patients with mild and moderate arterial hypertension, including ambulatory blood pressure monitoring (ABPM)." | 3.68 | [Treatment of systemic arterial hypertension with urapidil. Study in mild and moderate hypertension with ambulatory monitoring of arterial pressure]. ( Nobre, F; Nogueira, JL, 1993) |
| "Haemodynamic changes in the carotid and brachial arteries produced by single doses of four anti-hypertensive drugs (nicardipine, enalapril, atenolol, and urapidil) have been studied in 12 patients with essential hypertension." | 3.68 | Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil. ( Arosio, E; Lechi, A; Pancera, P; Priante, F; Ribul, M; Talamini, G; Zannoni, M, 1992) |
| "This report deals with two patients suffering from a closed head injury who demonstrated a rise of intracranial pressure (ICP) after bolus injections of urapidil to control arterial hypertension." | 3.68 | Urapidil-induced increase of the intracranial pressure in head-trauma patients. ( Metzger, G; Singbartl, G, 1990) |
| "In 19 infants and children with acute and severe hypertension following a cardiovascular operation urapidil infusion was started for treatment of the hypertensive crisis." | 3.67 | Urapidil therapy for acute hypertensive crises in infants and children. ( Bühlmeyer, K; Pilossoff, W; Schöber, JG, 1984) |
| "Central (six patients) and brachial (12 patients) haemodynamics were studied in men with sustained essential hypertension before and after intravenous administration of an alpha post-synaptic adrenergic blocking drug, urapidil." | 3.67 | Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension. ( Benetos, A; Bouthier, JD; Levenson, J; Safar, ME; Simon, AC, 1984) |
| "The clinical response and pharmacokinetics of intravenous urapidil were studied in patients with uncontrolled severe hypertension." | 3.67 | Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension. ( Bottorff, MB; Gerlach, PA; Hoon, TJ; Ramanathan, KB; Rodman, JH, 1988) |
| " injection of urapidil (Ebrantil) (25 mg) on arterial blood pressure, renal function and renin-aldosterone system were studied in a group of patients with hypertension and normal renal function, in patients with hypertension and chronic renal failure and in normotensive controls." | 3.67 | [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function]. ( Godehardt, E; Haerlin, R; Lang, R; Meurer, KA; Wambach, G, 1987) |
| "Systemic, renal and splanchnic hemodynamics and certain reflex and endocrine responses were determined in 10 patients with essential hypertension before and after intravenous administration of urapidil, a new antihypertensive agent that acts through both central and peripheral alpha-adrenergic inhibitory mechanisms." | 3.67 | Immediate hemodynamic effects of urapidil in patients with essential hypertension. ( Amodeo, C; Frohlich, ED; Kobrin, I; Messerli, FH; Ventura, HO, 1985) |
| "The pharmacokinetics, hypotensive effects, and safety of urapidil were investigated in 22 patients with essential hypertension at four coordinated centers in Japan." | 3.67 | Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan. ( Fujiwara, H; Iesaka, Y; Iizumi, T; Inada, M; Ito, H; Kirigaya, H; Nakamura, S; Nitta, M; Takeuchi, J; Taniguchi, K, 1985) |
| "Urapidil (Ebrantil) is a new antihypertensive agent exerting central and peripheral action which is recognized for the treatment of both chronic and acute hypertension." | 3.67 | [Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients]. ( Heimig, T; Lehmann, KA, 1985) |
| "The influence of urapidil, an arylpiperazinederivate, on intracranial pressure (ICP), mean arterial pressure (MAP) and cerebral perfusion pressure (CPP) was investigated in dogs with (group II) and without (group I) intracranial hypertension." | 3.66 | The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension. ( Anger, C; Lawin, P; Puchstein, C; Van Aken, H, 1983) |
| "urapidil is a safe and efficient alternative during surgical management of phaeochromocytoma." | 2.71 | Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. ( Ballanger, P; Gosse, P; Sesay, M; Tauzin-Fin, P, 2004) |
| "Urapidil was effective in 15 patients." | 2.70 | Effectiveness and safety of prehospital urapidil for hypertensive emergencies. ( Alijotas-Reig, J; Angles-Coll, R; Bove-Farre, I; de Cabo-Frances, F, 2001) |
| "Urapidil seems to be a good alternative to labetalol for attenuating the hypertensive response to ECT in cases where there is a contraindication to beta-antagonists." | 2.70 | Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy. ( Arcega, JM; Bernardo, M; Blanch, J; Faulí, A; Gomar, C; Imaz, ML; Martínez-Pallí, G; Navinés, R; Santos, P, 2001) |
| "Hypertension is one of the major cardiovascular risk factors." | 2.68 | [Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study]. ( Allaert, FA; Barrier, J; Blétry, O; Chamontin, B; Devulder, B; Godeau, P; Godin, M; Guillevin, L; Guilmot, JL; Luccioni, R, 1995) |
| "Atenolol treatment had neutral properties in some metabolic aspects, but deleterious effects on lipid status." | 2.68 | Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension. ( Haenni, A; Lithell, H, 1996) |
| "Urapidil treatment resulted to be effective in preventing hypertensive reactions following algogenic stimulation." | 2.68 | [Prevention of hypertensive crises in the perioperative period. Efficacy and safety of the use of urapidil]. ( Mastronardi, P; Mazzarella, B; Noseda, A; Santagata, T, 1996) |
| "Urapidil (U) has both peripheral alpha-1-adrenoreceptor blocking activity and a central antihypertensive effect at the level of the 5HT-1A serotonergic receptor, resulting in enhanced peripheral sympathetic inhibition (3,4)." | 2.67 | Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery. ( Koolen, JJ; Van der Stroom, JG; Van Wezel, HB; Van Zwieten, PA; Visser, CA, 1994) |
| " 24 patients discontinued the study due to adverse effects (n = 2), an inadequate effect (n = 2), or for reasons unrelated to therapy (n = 20); 58 (28." | 2.67 | [Long-term antihypertensive therapy with urapidil. A 3-year open, multicenter trial of tolerance, safety and effectiveness]. ( Harder, I; Liebau, H; Solleder, P; Wurst, W, 1990) |
| "Urapidil is a new antihypertensive agent involving both a peripheral and a central mode of action." | 2.66 | Acute responses to urapidil in hypertensive persons. ( Birkenhäger, WH; de Leeuw, PW, 1989) |
| "Urapidil was found effective in the treatment of hypertension during extracorporeal circulation." | 2.65 | Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine. ( Barankay, A; Göb, E; Richter, JA, 1981) |
| "Urapidil has an alpha-blocking effect but, unlike other alpha-blockers, also has a central sympatholytic effect mediated via stimulation of serotonin 5HT(1A) receptors in the central nervous system." | 2.46 | Urapidil, a dual-acting antihypertensive agent: Current usage considerations. ( Buch, J, 2010) |
| "Urapidil is a peripheral postsynaptic alpha 1-adrenoceptor antagonist with central agonistic action at serotonin 5-HT1A receptors." | 2.40 | Urapidil. A reappraisal of its use in the management of hypertension. ( Dooley, M; Goa, KL, 1998) |
| "A clear trend towards a reduction of cardiac hypertrophy during the treatment is suggested by the significant decrements of the indices measured." | 2.39 | Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil. ( Genovesi-Ebert, A; Ghione, S; Marabotti, C; Noseda, A; Spinazzi, A, 1994) |
| "Arterial hypertension is a well known risk factor for atherosclerosis and its complications." | 2.39 | Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience. ( Leonetti, G, 1994) |
| "(2) Urapidil is a selective alpha 1-adrenoceptor antagonist and, as such, a peripheral vasodilator." | 2.38 | Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity. ( Blauw, GJ; van Brummelen, P; van Zwieten, PA, 1990) |
| "Urapidil is a postsynaptic alpha 1-adrenoceptor antagonist with a pharmacodynamic profile similar to prazosin." | 2.38 | Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. ( Langtry, HD; Mammen, GJ; Sorkin, EM, 1989) |
| "Urapidil appears to be an effective antihypertensive drug with a wide spectrum of action and few side effects." | 2.37 | Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients? ( Doyle, AE, 1988) |
| "Urapidil is an alpha 1-adrenoceptor antagonist which also has a central antihypertensive effect, the mechanism of which has yet to be conclusively defined." | 2.37 | Urapidil in the treatment of hypertension. ( Rosendorff, C, 1988) |
| "Essential arterial hypertension is not a disease that would significantly adversely affect patients in their daily activities." | 1.72 | Urapidil: an unknown / known antihypertensive. ( Slíva, J, 2022) |
| "Nitroglycerine was the most commonly used antihypertensive treatment overall (40% of patients), followed by urapidil (21%), clonidine (16%) and furosemide (8%)." | 1.37 | Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). ( Anderson, FA; de La Garanderie, DP; Emery, L; Gore, JM; Rushton-Smith, S; Vincent, JL; Vuylsteke, A; Wyman, A, 2011) |
| "Urapidil is a potent antihypertensive drug that has been in clinical use for more than 20 years." | 1.35 | Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. ( Allegaert, K; Hanssens, M; Vanhaesebrouck, S, 2009) |
| "Urapidil was administered in 69 patients aged between 46-79 age (average 62." | 1.33 | [Usefulness of urapidil during intraoperative rise of arterial blood pressure in patients operated under general anesthesia]. ( Grabowska-Gaweł, A; Grześk, G; Porzych, K, 2005) |
| "Urapidil is a vasodilator acting on peripheral vessels by alpha-1 adrenoceptor blockade, and on central nervous system by alphaadrenoceptor blockade on the tractus solitarius nuclei and stimulation of serotoninergic receptors." | 1.29 | [Role of urapidil in the treatment of acute hypertension]. ( Bastien, O; Bonnefoy, E; Dalmas, JP; Filley, S; George, M; Lehot, JJ, 1995) |
| "treatment with urapidil at a diastolic blood pressure of more than 100 mm Hg." | 1.29 | [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. ( Bastert, G; Grischke, EM; Müller, J; Unkels, R; Wacker, J, 1994) |
| "Urapidil was given intravenously in the emergent treatment to the group of 23 pts in the mean dose of 50 mg." | 1.29 | [Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies]. ( Błaszyk, K; Cieśliński, A; Grajek, S; Mitkowski, P; Popiel, M; Skorupski, W; Wnuk, H, 1995) |
| "Hypertension is one of the major cardiovascular risk factors." | 1.29 | [Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)]. ( Allaert, FA; Barrier, J; Blétry, O; Chamontin, B; Devulder, B; Godeau, P; Godin, M; Guillevin, L; Guilmot, JL; Luccioni, R; Ninet, J; Serise, JM; Zannad, FM, 1996) |
| "Urapidil is a peripherally acting alpha 1-adrenoceptor antagonist, and, in this regard, is comparable with prazosin and its successor compounds (e." | 1.28 | [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug]. ( van Zwieten, PA, 1992) |
| "With urapidil treatment, the decrease in vascular resistance was distributed throughout all circulations, with no change in heart rate or cardiac index." | 1.27 | Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats. ( Frohlich, ED; Gallo, AJ; Kobrin, I; Natsume, T; Pegram, BL, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (34.62) | 18.7374 |
| 1990's | 81 (44.51) | 18.2507 |
| 2000's | 17 (9.34) | 29.6817 |
| 2010's | 18 (9.89) | 24.3611 |
| 2020's | 3 (1.65) | 2.80 |
| Authors | Studies |
|---|---|
| Slíva, J | 1 |
| Gish, A | 1 |
| Baes, D | 1 |
| Richeval, C | 1 |
| Wiart, JF | 1 |
| Hakim, F | 1 |
| Grenier, C | 1 |
| Allorge, D | 1 |
| Gaulier, JM | 1 |
| Xie, YZ | 1 |
| Ni, JM | 1 |
| Zhang, SJ | 1 |
| Ding, GR | 1 |
| Feng, JF | 1 |
| Herrera-Lasso, V | 1 |
| Dordal, MT | 1 |
| Alonso, G | 1 |
| Camprubí, I | 1 |
| Lleonart, R | 1 |
| Shi, J | 1 |
| Li, Y | 1 |
| Xing, C | 1 |
| Peng, P | 1 |
| Shi, H | 1 |
| Ding, H | 1 |
| Zheng, P | 1 |
| Ning, G | 1 |
| Feng, S | 1 |
| Cohen, DL | 1 |
| Townsend, RR | 1 |
| Meng, YF | 1 |
| Cui, GX | 1 |
| Gao, W | 1 |
| Li, ZW | 1 |
| Wang, F | 1 |
| Chen, B | 1 |
| Liu, Y | 1 |
| Tu, F | 1 |
| Salkic, S | 1 |
| Brkic, S | 1 |
| Batic-Mujanovic, O | 1 |
| Ljuca, F | 1 |
| Karabasic, A | 1 |
| Mustafic, S | 1 |
| Rabbia, F | 1 |
| D'Avolio, A | 1 |
| Bernini, G | 1 |
| Fulcheri, C | 1 |
| De Nicolò, A | 1 |
| Berra, E | 1 |
| Bruno, RM | 1 |
| Mulatero, P | 1 |
| Taddei, S | 1 |
| Veglio, F | 1 |
| Schweyer, L | 1 |
| Michels, G | 1 |
| Pfister, R | 1 |
| Yang, W | 1 |
| Zhou, YJ | 1 |
| Fu, Y | 1 |
| Qin, J | 1 |
| Qin, S | 1 |
| Chen, XM | 1 |
| Guo, JC | 1 |
| Wang, Z | 2 |
| Zhan, H | 1 |
| Li, J | 1 |
| He, JY | 1 |
| Hua, Q | 1 |
| Kuhlmann, U | 1 |
| Hoyer, J | 1 |
| Buch, J | 1 |
| Weismann, D | 1 |
| Kleinbrahm, K | 1 |
| Hu, K | 1 |
| Fassnacht, M | 1 |
| Frantz, S | 1 |
| Ertl, G | 1 |
| Allolio, B | 1 |
| Maier, SK | 1 |
| Wang, DF | 1 |
| Lou, N | 1 |
| Vuylsteke, A | 1 |
| Vincent, JL | 1 |
| de La Garanderie, DP | 1 |
| Anderson, FA | 1 |
| Emery, L | 1 |
| Wyman, A | 1 |
| Rushton-Smith, S | 1 |
| Gore, JM | 1 |
| Kobalava, ZhD | 1 |
| Kotovskaia, IuV | 1 |
| Bagmanova, NKh | 1 |
| Artiukhov, OP | 1 |
| Darmaeva, IP | 1 |
| Semenova, RI | 1 |
| Musina, NS | 1 |
| Minushkina, LO | 1 |
| Habbe, N | 1 |
| Ruger, F | 1 |
| Bojunga, J | 1 |
| Bechstein, WO | 1 |
| Holzer, K | 1 |
| Cherney, D | 1 |
| Straus, S | 1 |
| Stiefelhagen, P | 1 |
| Puttinger, H | 1 |
| Soleiman, A | 1 |
| Oberbauer, R | 1 |
| Tauzin-Fin, P | 1 |
| Sesay, M | 1 |
| Gosse, P | 1 |
| Ballanger, P | 1 |
| Suwelack, B | 1 |
| Welling, U | 1 |
| Hohage, H | 1 |
| Grabowska-Gaweł, A | 1 |
| Porzych, K | 1 |
| Grześk, G | 1 |
| Wacker, JR | 1 |
| Wagner, BK | 1 |
| Briese, V | 1 |
| Schauf, B | 1 |
| Heilmann, L | 1 |
| Bartz, C | 1 |
| Hopp, H | 1 |
| Woisetschläger, C | 4 |
| Bur, A | 4 |
| Vlcek, M | 1 |
| Derhaschnig, U | 1 |
| Laggner, AN | 6 |
| Hirschl, MM | 7 |
| Audibert, G | 1 |
| Charpentier, C | 1 |
| Seguin-Devaux, C | 1 |
| Charretier, PA | 1 |
| Grégoire, H | 1 |
| Devaux, Y | 1 |
| Perrier, JF | 1 |
| Longrois, D | 1 |
| Mertes, PM | 1 |
| Vanhaesebrouck, S | 1 |
| Hanssens, M | 1 |
| Allegaert, K | 1 |
| Van Zwieten, PA | 9 |
| Timmermans, PB | 1 |
| Van Brummelen, P | 4 |
| Mleczko-Nycz, Z | 1 |
| Kokot, F | 2 |
| Mertz, DP | 2 |
| Dittmann, EC | 1 |
| Zähringer, J | 1 |
| Klepzig, M | 1 |
| Greif, J | 1 |
| Ludwig, B | 1 |
| Strauer, B | 1 |
| Pegram, BL | 3 |
| Kobrin, I | 4 |
| Natsume, T | 1 |
| Gallo, AJ | 2 |
| Frohlich, ED | 4 |
| Schöber, JG | 1 |
| Pilossoff, W | 1 |
| Bühlmeyer, K | 1 |
| Levenson, J | 1 |
| Simon, AC | 1 |
| Bouthier, JD | 1 |
| Benetos, A | 1 |
| Safar, ME | 4 |
| Gallo, A | 1 |
| Kumar, A | 1 |
| Wiessmann, KJ | 1 |
| Münninghoff, J | 1 |
| Krüger, C | 1 |
| Van Aken, H | 3 |
| Puchstein, C | 2 |
| Anger, C | 1 |
| Lawin, P | 1 |
| Engelstätter, R | 1 |
| Barankay, A | 2 |
| Göb, E | 2 |
| Richter, JA | 3 |
| Becker, R | 1 |
| Fischer, R | 1 |
| Haerlin, R | 12 |
| Steinijans, V | 2 |
| Zech, K | 3 |
| Bruckschen, EG | 1 |
| Lehot, JJ | 1 |
| Bonnefoy, E | 1 |
| Dalmas, JP | 1 |
| Filley, S | 1 |
| Bastien, O | 1 |
| George, M | 1 |
| Petry, A | 1 |
| Wulf, H | 1 |
| Baumgärtel, M | 1 |
| Beregovaia, NIa | 1 |
| Fishchenko, AD | 1 |
| Vertkin, AL | 2 |
| Belousov, IuB | 1 |
| Martynov, AI | 2 |
| Grassi, G | 3 |
| Seravalle, G | 2 |
| Mancia, G | 4 |
| Zanchetti, A | 8 |
| Ghione, S | 2 |
| Genovesi-Ebert, A | 2 |
| Marabotti, C | 2 |
| Spinazzi, A | 5 |
| Noseda, A | 4 |
| Van der Stroom, JG | 3 |
| Van Wezel, HB | 3 |
| Koolen, JJ | 2 |
| Visser, CA | 1 |
| Ferrara, LA | 1 |
| Leonetti, G | 5 |
| Fogari, R | 1 |
| Mazzola, C | 2 |
| Mancini, M | 1 |
| Hansson, L | 3 |
| De Lima, MD | 1 |
| Kohlmann, NE | 1 |
| Neves, FA | 1 |
| Zanella, MT | 1 |
| Ribeiro, AB | 1 |
| Kohlmann, O | 1 |
| Ito, S | 1 |
| Kawamura, H | 1 |
| Maki, M | 1 |
| Tsukamoto, K | 1 |
| Komatsu, K | 1 |
| Mitsubayashi, H | 1 |
| Hara, K | 1 |
| Suzuki, K | 1 |
| Usui, W | 1 |
| Kanmasse, K | 1 |
| Lepage, JY | 1 |
| Pinaud, M | 1 |
| Hélias, J | 1 |
| Malinovsky, JM | 1 |
| Cozian, A | 1 |
| Petitet, A | 3 |
| Souron, R | 1 |
| Wacker, J | 4 |
| Müller, J | 1 |
| Grischke, EM | 1 |
| Unkels, R | 1 |
| Bastert, G | 4 |
| Seidler, D | 2 |
| Zeiner, A | 1 |
| Wagner, A | 1 |
| Heinz, G | 1 |
| Sterz, F | 1 |
| Nobre, F | 1 |
| Nogueira, JL | 1 |
| Amodeo, C | 2 |
| Barros, LM | 1 |
| Batlouni, M | 1 |
| Sousa, JE | 1 |
| Lewicka, S | 1 |
| Haack, D | 1 |
| Lal, KJ | 1 |
| Dakshinamurti, K | 1 |
| Chau, NP | 1 |
| Delamaire, M | 1 |
| Bernard, MD | 1 |
| Boisseau, MR | 1 |
| Späh, F | 2 |
| Walsemann, SO | 1 |
| Błaszyk, K | 1 |
| Grajek, S | 1 |
| Skorupski, W | 1 |
| Popiel, M | 1 |
| Wnuk, H | 1 |
| Mitkowski, P | 1 |
| Cieśliński, A | 1 |
| Vergroesen, I | 1 |
| Kal, JE | 2 |
| Dijkhuis, JP | 1 |
| Swaan, A | 1 |
| Porsius, M | 2 |
| Kleinjans, HA | 1 |
| Arosio, E | 3 |
| Pancera, P | 2 |
| Sheiban, I | 2 |
| Priante, F | 3 |
| Ribul, M | 2 |
| De Marchi, S | 1 |
| Tonni, S | 2 |
| Lechi, A | 3 |
| Godeau, P | 2 |
| Allaert, FA | 2 |
| Barrier, J | 2 |
| Blétry, O | 2 |
| Chamontin, B | 2 |
| Devulder, B | 2 |
| Godin, M | 2 |
| Guillevin, L | 2 |
| Guilmot, JL | 2 |
| Luccioni, R | 2 |
| Filosso, PL | 1 |
| Haenni, A | 1 |
| Lithell, H | 1 |
| Oren, S | 1 |
| Turkot, S | 1 |
| Paran, E | 1 |
| Flandra, O | 1 |
| Slezak, L | 1 |
| Hof, B | 1 |
| Müllner, M | 2 |
| Kürkciyan, I | 1 |
| Herkner, H | 3 |
| Mastronardi, P | 1 |
| Santagata, T | 1 |
| Mazzarella, B | 1 |
| Malbrain, ML | 1 |
| Wyffels, E | 1 |
| Lins, RL | 1 |
| Daelemans, R | 1 |
| Müller, M | 1 |
| Binder, M | 3 |
| Ninet, J | 1 |
| Serise, JM | 1 |
| Zannad, FM | 1 |
| Langemeijer, JJ | 1 |
| Korsten, HH | 1 |
| Kooyman, J | 1 |
| van der Starre, PJ | 1 |
| van den Ende, R | 1 |
| Werner, P | 1 |
| Walter-Sack, I | 1 |
| Gamper, G | 1 |
| Frossard, M | 1 |
| Domingo Triadó, V | 1 |
| Bovaira Forner, M | 1 |
| Viñoles Pérez, JM | 1 |
| Cabezudo de la Muela, L | 1 |
| Negueroles Albuixech, D | 1 |
| Moro Blázquez, B | 1 |
| Wenzel, UO | 1 |
| Stahl, RA | 1 |
| Grieshaber, M | 1 |
| Schwietzer, G | 1 |
| Schreiber, W | 1 |
| Kaff, A | 1 |
| Raab, H | 1 |
| Dooley, M | 1 |
| Goa, KL | 1 |
| Schiesser, M | 1 |
| Zafiriou, N | 1 |
| Schulz, M | 1 |
| Stella, ML | 1 |
| Turri, C | 1 |
| Lavrijssen, AT | 1 |
| Kroon, AA | 1 |
| Fuss-Lejeune, M | 1 |
| Schiffers, PM | 1 |
| de Leeuw, PW | 3 |
| Golikov, PP | 1 |
| Davydov, BV | 1 |
| Marchenko, VV | 1 |
| Nikolaeva, NIu | 1 |
| Golikov, AP | 1 |
| Riabinin, VA | 1 |
| Semenova, EV | 1 |
| Polumiskov, VIu | 1 |
| Olmos, M | 1 |
| Vidarte, MA | 1 |
| Ballester, JA | 1 |
| Lasuen, J | 1 |
| Escobar, A | 1 |
| Alijotas-Reig, J | 1 |
| Bove-Farre, I | 1 |
| de Cabo-Frances, F | 1 |
| Angles-Coll, R | 1 |
| Blanch, J | 1 |
| Martínez-Pallí, G | 1 |
| Navinés, R | 1 |
| Arcega, JM | 1 |
| Imaz, ML | 1 |
| Santos, P | 1 |
| Faulí, A | 1 |
| Bernardo, M | 1 |
| Gomar, C | 1 |
| Karim, S | 1 |
| Zubair, M | 1 |
| Blauw, GJ | 3 |
| Montresor, G | 1 |
| Palombo, C | 1 |
| Cattaneo, G | 1 |
| Man in 't Veld, AJ | 1 |
| Fariello, R | 2 |
| Boni, E | 1 |
| Corda, L | 1 |
| Zaninelli, A | 1 |
| Ol'binskaia, LI | 1 |
| Gogin, EE | 1 |
| Zadionchenko, VS | 1 |
| Martynov, IV | 1 |
| Kolassa, N | 1 |
| Man int Vel'd, AI | 1 |
| Sidorenko, BA | 1 |
| Belova, EV | 1 |
| Sampieri, L | 1 |
| Cuspidi, C | 1 |
| Terzoli, L | 2 |
| Zannoni, M | 1 |
| Talamini, G | 1 |
| Levy, BI | 2 |
| Poitevin, P | 2 |
| Antonicelli, R | 1 |
| Balducci, E | 1 |
| Lipponi, G | 1 |
| Lucantoni, C | 1 |
| Gaetti, R | 1 |
| Paciaroni, E | 1 |
| Distler, A | 1 |
| Hilgenstock, G | 1 |
| Passfall, J | 1 |
| Franz, IW | 1 |
| Tönnesmann, U | 1 |
| Erb, D | 1 |
| Ketelhut, R | 1 |
| Grosser, KD | 1 |
| Thieme, G | 2 |
| Dal Palu, C | 1 |
| Pessina, A | 1 |
| Semplicini, A | 1 |
| Pirrelli, A | 1 |
| Vulpis, V | 1 |
| Carretta, R | 1 |
| Bellini, G | 1 |
| Buoninconti, R | 1 |
| Wurst, W | 8 |
| Zitta, S | 1 |
| Holzer, H | 1 |
| Dietzel, K | 1 |
| Taucher, J | 1 |
| Cazzola, M | 1 |
| Santangelo, G | 1 |
| Steinijans, VW | 4 |
| Solleder, P | 4 |
| Girbino, G | 1 |
| Hess, W | 2 |
| Quéré, JF | 2 |
| Ozier, Y | 2 |
| Bringier, J | 2 |
| Morot, B | 2 |
| Bernard, D | 2 |
| Pigot, B | 2 |
| Conseiller, C | 2 |
| Liebau, H | 2 |
| Harder, I | 2 |
| M'Buyamba-Kabangu, JR | 1 |
| Bielen, E | 2 |
| Staessen, J | 2 |
| Fagard, R | 2 |
| Lijnen, P | 2 |
| Van Hoof, R | 2 |
| Amery, A | 2 |
| Sebeková, K | 1 |
| Fedelesová, V | 1 |
| Blazícek, P | 1 |
| Dzúrik, R | 2 |
| Paulin, L | 1 |
| Bonezzi, C | 1 |
| Bonacina, M | 1 |
| Miotti, D | 1 |
| De Falco, A | 1 |
| Demartini, L | 1 |
| Lorini, FL | 1 |
| Sonzogni, V | 1 |
| Di Dedda, G | 1 |
| Brevi, M | 1 |
| Ricucci, G | 1 |
| Möllhoff, T | 2 |
| Mulier, JP | 2 |
| Müller, E | 2 |
| Lauwers, P | 2 |
| Singbartl, G | 1 |
| Metzger, G | 1 |
| Marty, J | 1 |
| Pansart, JL | 1 |
| Lançon, JP | 1 |
| Aoki, K | 1 |
| Asano, M | 1 |
| Matsuda, T | 1 |
| Hussein, S | 1 |
| Seifert, V | 1 |
| Stumpe, KO | 1 |
| Feldhaus, P | 2 |
| Birkenhäger, WH | 2 |
| Langtry, HD | 1 |
| Mammen, GJ | 1 |
| Sorkin, EM | 1 |
| Scherer, R | 1 |
| Kirsten, R | 4 |
| Nelson, K | 4 |
| Kirch, W | 1 |
| Hutt, HJ | 1 |
| Molz, KH | 2 |
| Theodor, R | 1 |
| Nieder, M | 1 |
| Dilger, C | 1 |
| Sirakova, V | 2 |
| Penkov, N | 2 |
| Kaponov, Kh | 1 |
| van Es, PN | 1 |
| de Bruyn, HA | 1 |
| Takeda, T | 1 |
| Kaneko, Y | 2 |
| Shionoiri, H | 1 |
| Yasuda, H | 1 |
| Iimura, O | 1 |
| Yoshinaga, K | 1 |
| Inagaki, Y | 1 |
| Ishii, M | 1 |
| Taniguchi, K | 2 |
| Mizuno, Y | 1 |
| Doyle, AE | 1 |
| Warren, JB | 1 |
| Dollery, CT | 1 |
| Rosenthal, J | 4 |
| Schäfer, N | 2 |
| Christ, B | 1 |
| Török, E | 1 |
| Wagner, M | 1 |
| Podmaniczky, M | 1 |
| Rosendorff, C | 1 |
| Messerli, FH | 2 |
| Penev, A | 1 |
| Wiechmann, HW | 1 |
| Román, O | 1 |
| Sudy, E | 1 |
| Gac, JC | 1 |
| Valenzuela, MA | 1 |
| Bottorff, MB | 1 |
| Hoon, TJ | 1 |
| Rodman, JH | 1 |
| Gerlach, PA | 1 |
| Ramanathan, KB | 1 |
| Parati, G | 1 |
| Pomidossi, G | 1 |
| Giannattasio, G | 1 |
| Casadei, R | 1 |
| Groppelli, A | 1 |
| Trimarco, B | 1 |
| Rosiello, G | 1 |
| Vecchione, F | 1 |
| Cuocolo, A | 1 |
| Lembo, G | 1 |
| Volpe, M | 1 |
| Culbertson, VL | 1 |
| Bryant, PJ | 1 |
| Cady, WJ | 1 |
| Rubison, RM | 1 |
| Piepho, RW | 1 |
| Nies, AS | 1 |
| Byyny, RL | 1 |
| Boni, S | 1 |
| Guffanti, E | 1 |
| Meani, A | 1 |
| Wambach, G | 1 |
| Godehardt, E | 1 |
| Lang, R | 1 |
| Meurer, KA | 1 |
| Bułanowski, Z | 1 |
| Grzeszczak, W | 1 |
| Duława, J | 1 |
| Thuma, G | 1 |
| Neff, J | 1 |
| Radtke, HW | 1 |
| Schulte-Sasse, U | 1 |
| Tarnow, J | 1 |
| Veit, S | 1 |
| Kanniainen, E | 1 |
| Heikkilä, O | 1 |
| Jääskeläinen, T | 1 |
| Lilja, M | 1 |
| Jounela, AJ | 1 |
| Fetkovská, N | 1 |
| Ventura, HO | 1 |
| Nakamura, S | 1 |
| Iesaka, Y | 1 |
| Nitta, M | 1 |
| Ito, H | 1 |
| Kirigaya, H | 1 |
| Takeuchi, J | 1 |
| Fujiwara, H | 1 |
| Iizumi, T | 1 |
| Inada, M | 1 |
| Rumiński, W | 1 |
| Markiewicz, M | 1 |
| Grzywna, R | 1 |
| Kleinrok, A | 1 |
| Lehmann, KA | 1 |
| Heimig, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia In Patients Undergoing Elective Thyroidectomy. A Randomized Controlled Study[NCT04471597] | 48 participants (Actual) | Interventional | 2020-07-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
29 reviews available for urapidil and Blood Pressure, High
| Article | Year |
|---|---|
Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis.
Topics: Acute Disease; Heart Failure; Humans; Hypertension; Nitroglycerin; Piperazines; Randomized Controlle | 2019 |
[Hypertensive emergency].
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Emergencies; Humans; Hypertension; Nitr | 2008 |
Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertensi | 2010 |
[Hypertensive crisis in cardiology: place of urapidil].
Topics: Antihypertensive Agents; Drug Monitoring; Heart Rate; Hemodynamics; Humans; Hypertension; Injections | 2012 |
[Features of urapidil in treatment of resistant hypertension].
Topics: Adrenergic alpha-1 Receptor Antagonists; Blood Pressure; Humans; Hypertension; Piperazines; Treatmen | 2012 |
Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature.
Topics: Antihypertensive Agents; Blood Pressure Determination; Clinical Trials as Topic; Critical Illness; E | 2002 |
[Hypertensive crisis: what to do in emergencies?].
Topics: Antihypertensive Agents; Blood Pressure Determination; Chest Pain; Critical Care; Dyspnea; Emergenci | 2004 |
Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Azepines; | 1984 |
Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
Topics: Antihypertensive Agents; Blood Pressure; Cardiomegaly; Clinical Trials as Topic; Heart; Heart Rate; | 1994 |
Treatment of hypertension in the elderly with special reference to urapidil.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Female; Humans; Hyper | 1994 |
Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy; Humans; Hypertension; Piperazines; R | 1994 |
Review of studies with urapidil in elderly hypertensives.
Topics: Aging; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Piperazines | 1995 |
[The treatment of intraoperative arterial hypertension with Urapidil].
Topics: Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Intraoperative Care; Intraoperative Com | 1996 |
Urapidil. A reappraisal of its use in the management of hypertension.
Topics: Antihypertensive Agents; Cerebrospinal Fluid Pressure; Fibrinolysis; Heart; Humans; Hypertension; Ki | 1998 |
Serotonergic receptors and drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Anim | 1992 |
Clinical pharmacology, efficacy and safety of a new alpha 1 adrenoceptor antagonist with an additional central action, in hypertension.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Humans; Hypertension; Piperazines | 1992 |
Influence of urapidil and other antihypertensive agents on lipids and glucose metabolism in hypertensive patients.
Topics: Antihypertensive Agents; Glucose; Humans; Hypertension; Lipoproteins; Piperazines | 1992 |
Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension | 1990 |
Haemodynamic effects of the multiple action antihypertensive drug urapidil.
Topics: Antihypertensive Agents; Blood Pressure; Cardiac Output; Hemodynamics; Humans; Hypertension; Piperaz | 1990 |
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Ketanserin; Piperaz | 1990 |
Urapidil-induced hemodynamic changes in humans.
Topics: Acute Disease; Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertens | 1989 |
Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Topics: Animals; Humans; Hypertension; Piperazines | 1989 |
[The use of urapidil to control peroperative attacks of hypertension. 5 years' experience in West Germany].
Topics: Antihypertensive Agents; Germany, West; Humans; Hypertension; Intraoperative Period; Piperazines; Su | 1989 |
Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Hemodynamics; Human | 1988 |
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Ketanserin; Labetalol; | 1988 |
The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Indoramin; Labetalol; P | 1988 |
Urapidil in the treatment of hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Female; Humans; Hypertension; Male; Middle Aged; Piperazines | 1988 |
Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.
Topics: Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines | 1988 |
Clinical pharmacokinetics of urapidil.
Topics: Adult; Aged; Aged, 80 and over; Aging; Digoxin; Drug Interactions; Half-Life; Humans; Hypertension; | 1988 |
74 trials available for urapidil and Blood Pressure, High
| Article | Year |
|---|---|
Local airway anesthesia attenuates hemodynamic responses to intubation and extubation in hypertensive surgical patients.
Topics: Airway Extubation; Amides; Anesthesia, Local; Antihypertensive Agents; Arterial Pressure; Demography | 2014 |
[Effect of urapidil combined with phentolamine on hypertension during extracorporeal circulation].
Topics: Extracorporeal Circulation; Heart Rate; Humans; Hypertension; Interleukin-6; Phentolamine; Piperazin | 2014 |
Emergency Room Treatment of Hypertensive Crises.
Topics: Acute Disease; Administration, Intravenous; Administration, Sublingual; Adrenergic alpha-1 Receptor | 2015 |
Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Heart Failure; | 2017 |
Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Catecholamines; | 2004 |
Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dihydralazine; Dose-Response Relationship, Drug; Fem | 2006 |
Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies.
Topics: Administration, Oral; Captopril; Female; Humans; Hypertension; Injections, Intravenous; Male; Middle | 2006 |
[Treatment of hypertensive crisis with ebrantil (urapidil)].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertensi | 1984 |
Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine.
Topics: Aged; Anesthesia; Antihypertensive Agents; Cardiopulmonary Bypass; Hemodynamics; Humans; Hypertensio | 1981 |
The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anesthesia, General; Antihypertensive Agents; Double-Blin | 1995 |
[A clinical assessment of ebrantil efficacy in arterial hypertension patients].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension; Male; | 1995 |
Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery.
Topics: Antihypertensive Agents; Blood Pressure; Coronary Vessels; Echocardiography; Heart; Heart Rate; Hemo | 1994 |
Urapidil in hypercholesterolemic hypertensive patients.
Topics: Antihypertensive Agents; Female; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Ag | 1994 |
Treatment of hypertension in the elderly with special reference to urapidil.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Female; Humans; Hyper | 1994 |
Acute effects of urapidil on left ventricular function in hypertensive patients: comparison with clonidine using radionuclide angiography.
Topics: Adrenergic alpha-Antagonists; Aged; Clonidine; Double-Blind Method; Heart; Hemodynamics; Humans; Hyp | 1994 |
Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.
Topics: Acute Disease; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; | 1993 |
[Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hypertens | 1993 |
Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Co | 1995 |
Comparison of the effects of urapidil and sodium nitroprusside on haemodynamic state, myocardial metabolism and function in patients during coronary artery surgery.
Topics: Adult; Aged; Antihypertensive Agents; Blood Flow Velocity; Cardiac Output; Coronary Vessels; Echocar | 1996 |
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study].
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Brain Ischemia; Cardiovascular Diseases; Drug Ther | 1995 |
Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method | 1996 |
Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure Determination; Diabetes Mellitus, Type 2; | 1996 |
[Prevention of hypertensive crises in the perioperative period. Efficacy and safety of the use of urapidil].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti | 1996 |
Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Emergencies; Female; Humans; H | 1997 |
A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
Topics: Aged; Antihypertensive Agents; Coronary Vessels; Double-Blind Method; Hemodynamics; Humans; Hyperten | 1997 |
Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diastole; Dihydralazine; Female; Heart Rate; Humans; | 1998 |
Course of blood pressure within the first 12 h of hypertensive urgencies.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Emergencie | 1998 |
The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Chi-Square D | 1998 |
Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Heart Rate; | 2000 |
Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Ca | 2000 |
[Efficacy of a single dose of urapidil for preventing arterial hypertension during the pre-bypass period in coronary surgery].
Topics: Adult; Aged; Antihypertensive Agents; Coronary Artery Bypass; Extracorporeal Circulation; Female; He | 2000 |
Effectiveness and safety of prehospital urapidil for hypertensive emergencies.
Topics: Adrenergic alpha-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Emergency Medical | 2001 |
Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, | 2001 |
Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Cardiomegaly; Female; Heart Ventricles | 1992 |
Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Cardiomegaly; Double-Blind Method; Ech | 1992 |
Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Diab | 1992 |
[Role of urapidil in the treatment of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Animals; Antihypertensive Agents; Blood Pressure; Cats; Female; | 1992 |
Biochemical effects of urapidil on red cell membrane ion transport systems in a population of elderly essential hypertensives.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Biological Transport, Active; Double-Blind Method; | 1991 |
Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Heart Rate; Hu | 1990 |
Ergometry as a basis for judging the antihypertensive effect.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Exercise Test; Female; Humans; Hyperte | 1990 |
Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination | 1990 |
Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Antihypertensive Agents; Female; Forced Expiratory Volume; Humans; Hypertension; Lung D | 1990 |
Urapidil versus clonidine. Acute haemodynamic effects during control of intraoperative hypertensive episodes.
Topics: Antihypertensive Agents; Clonidine; Coronary Artery Bypass; Double-Blind Method; Hemodynamics; Human | 1990 |
Does urapidil attenuate the blood pressure response to tracheal intubation for general anaesthesia?
Topics: Anesthesia, General; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; H | 1990 |
[Long-term antihypertensive therapy with urapidil. A 3-year open, multicenter trial of tolerance, safety and effectiveness].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Humans; Hypertension; Long-Term Car | 1990 |
Acute effect of urapidil on peripheral serotonin metabolism.
Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension; Male; Middle Aged; Piperazines; Platel | 1990 |
[Does urapidil attenuate the hypertensive response to tracheal intubation at the time of general anesthesia?].
Topics: Adult; Aged; Anesthesia, General; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hype | 1990 |
Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting.
Topics: Antihypertensive Agents; Coronary Artery Bypass; Heart Rate; Hemodynamics; Humans; Hypertension; Ket | 1990 |
[Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Meth | 1989 |
Acute responses to urapidil in hypertensive persons.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Catecholamines; Clinical Trials as Topic; Double-Bli | 1989 |
[The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery].
Topics: Antihypertensive Agents; Coronary Artery Bypass; Coronary Disease; Ferricyanides; Hemodynamics; Huma | 1989 |
Improved orthostatic dysregulation record after administration of a sustained-release form of urapidil.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Female; Half-Life | 1989 |
Renal haemodynamic and neurohumoral responses to urapidil in hypertensive man.
Topics: Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Clinical Trial | 1988 |
Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Clinical Trials as Topic; Hemodynamics; Human | 1988 |
Urapidil in patients with severe hypertension and in long-term treatment.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Diuretics; Drug Therapy, Co | 1988 |
Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Double | 1988 |
Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, C | 1988 |
Comparison of urapidil and atenolol in hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Bli | 1988 |
Treatment of mild hypertension with urapidil or captopril.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness | 1988 |
[Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Heart Ventricles; Hemodynamics; Humans; Hy | 1988 |
Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hypertension; | 1988 |
[Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
Topics: Antihypertensive Agents; Blood Glucose; Clinical Trials as Topic; Female; Humans; Hypertension; Lipi | 1988 |
[Hemodynamic effects of different antihypertensive combinations].
Topics: Acebutolol; Antihypertensive Agents; Captopril; Chronic Disease; Diuretics; Drug Evaluation; Drug Th | 1988 |
[Urapidil in primary arterial hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dose-Response Relati | 1987 |
Neural control of circulation before and after intravenous urapidil in essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Carotid Sinus; Central Venous Pressure; Cold Temperature; H | 1988 |
Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Electrocardiogra | 1988 |
Acute effects of increasing doses of urapidil in patients with hypertension.
Topics: Adult; Analysis of Variance; Blood Pressure; Chromatography, High Pressure Liquid; Clinical Trials a | 1986 |
Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hy | 1986 |
[Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Double | 1986 |
Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: a crossover study comparing infusion with an infusion-capsule combination.
Topics: Blood Pressure; Capsules; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Kinetics; Male; | 1987 |
Pharmacodynamics and pharmacokinetics of three different doses of urapidil infused in hypertensive patients.
Topics: Aged; Biotransformation; Blood Pressure; Humans; Hypertension; Kinetics; Male; Middle Aged; Piperazi | 1986 |
Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery.
Topics: Acute Disease; Adrenal Gland Neoplasms; Anesthesia, General; Antihypertensive Agents; Coronary Arter | 1985 |
Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Clonidine; Double-Blind Me | 1985 |
[Treatment of hypertension with urapidil].
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle | 1985 |
81 other studies available for urapidil and Blood Pressure, High
| Article | Year |
|---|---|
Urapidil: an unknown / known antihypertensive.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Piperazines | 2022 |
2-MeOPP positive hair result in case of urapidil treatment.
Topics: Antihypertensive Agents; Humans; Hypertension; Piperazines | 2023 |
Efficacy of urapidil for the treatment of patients with senile hypertension and acute heart failure.
Topics: Acute Disease; Antihypertensive Agents; Heart Failure; Humans; Hypertension; Piperazines; Randomized | 2019 |
Kounis Syndrome due to Urapidil.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Allergens; Anaphylaxis; Antihypertensive Agents; Coro | 2021 |
Is BP lowering during acute intracerebral hemorrhage safe?
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive | 2013 |
Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relati | 2016 |
[The pedagogical approach to pharmacology in nurse training institutes].
Topics: Academies and Institutes; Aged, 80 and over; Curriculum; Deglutition; Dosage Forms; Education, Nursi | 2016 |
[71-year old woman with arterial hypertension and oral finding].
Topics: Aged; Amlodipine; Diagnosis, Differential; Drug Substitution; Female; Gingival Hyperplasia; Humans; | 2016 |
Prevention of hypertensive crises in rats induced by acute and chronic norepinephrine excess.
Topics: Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Hemodynamics; Hypertension; Infu | 2010 |
[Efficacy of sublingual nifedipine and intravenous urapidil for treatment of acute postoperative hypertension].
Topics: Administration, Sublingual; Aged; Antihypertensive Agents; Female; Humans; Hypertension; Injections, | 2011 |
Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT).
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Emergency Service, Hospital | 2011 |
[Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease].
Topics: Administration, Oral; Adult; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged | 2012 |
Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonist | 2013 |
[When hypertension becomes an emergency case: lower the blood pressure, but slowly!].
Topics: Administration, Oral; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diagnosis, Diffe | 2003 |
Regression of hypertensive nephropathy during three years of optimal blood pressure control.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Biopsy; Echocardiography; Emergencies; | 2003 |
[Usefulness of urapidil during intraoperative rise of arterial blood pressure in patients operated under general anesthesia].
Topics: Aged; Anesthesia, General; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; In | 2005 |
Improvement of donor myocardial function after treatment of autonomic storm during brain death.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Brain Death; Cohort Studies; Creat | 2006 |
Neonatal transient respiratory depression after maternal urapidil infusion for hypertension.
Topics: Adult; Antihypertensive Agents; Cesarean Section; Dose-Response Relationship, Drug; Female; Humans; | 2009 |
[Lipid metabolism in hypertensive therapy. Measurements of electrolytes, lipids and lipoproteins in blood of normal and hypertensive individuals during repeated administration of Ebrantil].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Electrolytes; Female; Heart Rate; Humans; Hype | 1983 |
[Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
Topics: Acute Disease; Antihypertensive Agents; Coronary Disease; Echocardiography; Female; Hemodynamics; Hu | 1984 |
Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; | 1984 |
Urapidil therapy for acute hypertensive crises in infants and children.
Topics: Acute Disease; Adolescent; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Central | 1984 |
Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension.
Topics: Blood Flow Velocity; Blood Pressure; Brachial Artery; Compliance; Hemodynamics; Humans; Hypertension | 1984 |
Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Heart; Heart Rate; Hemodynamics; Hypertension; Mal | 1984 |
Immediate hemodynamic changes produced by urapidil in normotensive and spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hemo | 1984 |
[Antihypertensive therapy using urapidil in patients with obstructive lung diseases].
Topics: Adult; Aged; Antihypertensive Agents; Blood Gas Analysis; Drug Evaluation; Female; Hemodynamics; Hum | 1983 |
The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension.
Topics: Anesthesia, Conduction; Animals; Blood Pressure; Brain; Cerebrovascular Circulation; Dogs; Hypertens | 1983 |
[Effect of ebrantil, a new antihypertensive agent, on lipid metabolism and electrolyte balance].
Topics: Adult; Aged; Antihypertensive Agents; Cholesterol; Cholesterol, VLDL; Electrolytes; Female; Humans; | 1982 |
Treatment of hypertension in coronary bypass surgery. Clinical experience with urapidil.
Topics: Adult; Aged; Coronary Artery Bypass; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hyperte | 1981 |
[Urapidil--a new antihypertensive agent].
Topics: Antihypertensive Agents; Humans; Hypertension; Piperazines | 1982 |
Preliminary results on the correlation between serum level and antihypertensive effect of urapidil (Ebrantil).
Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension; Male; Piperazines; Time Factors; Uraci | 1981 |
[Role of urapidil in the treatment of acute hypertension].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensi | 1995 |
Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Heart Rate; Humans; Hypertension; Per | 1994 |
Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
Topics: Adult; Antihypertensive Agents; Chlorthalidone; Female; Glucose; Humans; Hydrochlorothiazide; Hypert | 1994 |
[Effect of calcium antagonist (benidipine) and alpha 1 blocker (urapidil) on renal hemodynamic responses to two acute environmental stresses in spontaneously hypertensive rats (SHR)].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Calcium Channel Blockers; Dihydropyridines; Fe | 1994 |
[Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Dihydralazine; Drug Administration | 1994 |
[Treatment of systemic arterial hypertension with urapidil. Study in mild and moderate hypertension with ambulatory monitoring of arterial pressure].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Protocols; Electrocardiography, Ambul | 1993 |
Hypertension in pregnancy.
Topics: Antihypertensive Agents; Blood Pressure Determination; Female; Humans; Hypertension; Leukocytes, Mon | 1993 |
Hypotensive action of 5-HT receptor agonists in the vitamin B6-deficient hypertensive rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antihypertensive Agents; Blood Pressure; Cerebral C | 1993 |
Blood pressure and serum lipids in hypertensive men and women aged 60-97 years.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Cholesterol, | 1995 |
Hemorheology of arterial hypertension: influence of urapidil.
Topics: Antihypertensive Agents; Blood Platelets; Blood Viscosity; Hemorheology; Humans; Hypertension; Piper | 1995 |
Potential beneficial effects of urapidil in primary and secondary prevention of stroke.
Topics: Antihypertensive Agents; Cerebrovascular Disorders; Humans; Hypertension; Piperazines | 1995 |
Adaptation of antihypertensive drug treatment with increasing age: from the young to the elderly. Focus on urapidil.
Topics: Adult; Aged; Aging; Antihypertensive Agents; Humans; Hypertension; Middle Aged; Piperazines | 1995 |
[Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Emergencies; Female; Heart Rate; Humans; Hypertens | 1995 |
Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
Topics: Adult; Antihypertensive Agents; Diastole; Female; Hemodynamics; Humans; Hypertension; Male; Middle A | 1996 |
Efficacy of different antihypertensive drugs in the emergency department.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Emergency Medical Services; Enalaprilat; Femal | 1996 |
Treating hypertensive patients with intracranial pathology.
Topics: Antihypertensive Agents; Brain Diseases; Humans; Hypertension; Piperazines | 1996 |
Treating hypertensive patients with intracranial pathology.
Topics: Antihypertensive Agents; Brain Diseases; Enalaprilat; Humans; Hypertension; Piperazines | 1996 |
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)].
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Drug Evaluation; Electrocardiography; Female | 1996 |
[Therapy of hypertensive crises. Profile of intravenous Ebrantil].
Topics: Antihypertensive Agents; Humans; Hypertension; Hypertension, Pulmonary; Injections, Intravenous; Int | 1994 |
[Control of hypertensive crisis with urapidil in two cases of adrenalectomy].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Female; Humans; Hyp | 1998 |
[Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis. An inquiry in 56 internal medicine clinics].
Topics: Acute Disease; Administration, Sublingual; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists | 1998 |
[Doppler ultrasound findings in therapy with urapidil].
Topics: Adult; Antihypertensive Agents; Female; Fetus; Humans; Hypertension; Infant, Newborn; Infusions, Int | 1999 |
[Urapidil effects on oxidative stress in hypertensive crises].
Topics: Acute Disease; Adult; Aged; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Injection | 2000 |
Urapidil and enuresis.
Topics: Antihypertensive Agents; Enuresis; Female; Humans; Hypertension; Male; Middle Aged; Piperazines | 1992 |
[Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Piperazin | 1992 |
Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Enalapr | 1992 |
Effects of alpha 1-blockade on arterial compliance in normotensive and hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid Arteries; Elasticity; Hemodynamics; H | 1991 |
Hybrid or multifactorial drugs in antihypertensive treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Combination | 1990 |
International symposium on urapidil. Proceedings of a satellite symposium entitled 'Multiple Action Antihypertensive Therapy with Special Reference to Alpha- and 5-HT-Receptors', Berlin, 16 June 1990.
Topics: Animals; Antihypertensive Agents; Humans; Hypertension; Piperazines | 1990 |
Acute haemodynamic effects of urapidil and nifedipine in hypertensive urgencies and emergencies.
Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Emergencies; Female; Heart Rate; He | 1990 |
Pharmacokinetics of urapidil in patients with impaired renal function.
Topics: Adult; Aged; Antihypertensive Agents; Humans; Hypertension; Injections, Intravenous; Kidney; Kidney | 1990 |
Effects of urapidil on the mechanical properties of the arterial wall in hypertension.
Topics: Animals; Antihypertensive Agents; Arteries; Brachial Artery; Carotid Arteries; Humans; Hypertension; | 1990 |
[Hemodynamic effects of urapidil in men].
Topics: Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; | 1990 |
[Control of arterial pressure in 86 patients treated with Urapidil both during the intra- and postoperative period].
Topics: Antihypertensive Agents; Humans; Hypertension; Intraoperative Care; Piperazines; Postoperative Care | 1990 |
[Control with urapidil of hypertensive crisis during myocardial revascularization].
Topics: Antihypertensive Agents; Coronary Artery Bypass; Hemodynamics; Humans; Hypertension; Intraoperative | 1990 |
Urapidil-induced increase of the intracranial pressure in head-trauma patients.
Topics: Adolescent; Antihypertensive Agents; Cerebrovascular Circulation; Craniocerebral Trauma; Humans; Hyp | 1990 |
[The use of urapidil for the treatment of hypertension during aortocoronary bypass].
Topics: Antihypertensive Agents; Coronary Artery Bypass; Humans; Hypertension; Intraoperative Complications; | 1990 |
Antagonism of alpha 1-adrenoceptor-mediated vascular contraction by urapidil in isolated arterial strips of spontaneously hypertensive rats.
Topics: Age Factors; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Hypertension; In Vi | 1988 |
[The postoperative treatment of hypertension with urapidil in patients with cerebrovascular aneurysms].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Intracranial Ane | 1989 |
Treatment of hypertensive outbreaks in cardiovascular surgery.
Topics: Antihypertensive Agents; Aortic Valve Insufficiency; Cardiac Surgical Procedures; Hemodynamics; Huma | 1989 |
Treatment of hypertensive crises in neurosurgery.
Topics: Animals; Antihypertensive Agents; Cerebrovascular Circulation; Dogs; Hemodynamics; Humans; Hypertens | 1989 |
[Treatment of hypertension with urapidil (Ebrantil)].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Capsules; Delayed-Action Preparations; | 1986 |
Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male | 1988 |
[Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
Topics: Adrenal Glands; Adult; Antihypertensive Agents; Blood Pressure; Female; Heart Rate; Humans; Hyperten | 1987 |
[Effect of urapidil on adrenal cortex activity and prolactin secretion in patients with idiopathic hypertension].
Topics: Adrenal Cortex; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; | 1986 |
[Urapidil as a basic drug in severe hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Age | 1986 |
Immediate hemodynamic effects of urapidil in patients with essential hypertension.
Topics: Antihypertensive Agents; Cardiovascular System; Echocardiography; Female; Hemodynamics; Humans; Hype | 1985 |
Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Evaluation; Female; Heart Rate; Humans; H | 1985 |
[Effect of ebrantil on selected hemodynamic parameters in patients with hypertension in the acute phase of myocardial infarction].
Topics: Adult; Aged; Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Middle Aged; Myocardial | 1985 |
[Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients].
Topics: Adult; Aged; Anesthesia, General; Anesthesia, Local; Antihypertensive Agents; Diazepam; Droperidol; | 1985 |